SLC1A5 and neoplasm: Through in vitro experiments on CMM cell lines and in vivo trials in seven canine cases, they revealed that miR-634 induced apoptosis by downregulating Asct2, Nrf2, and surviving expression, observing anti-tumor effects in four cases without adverse reactions.